SCHEMBL7918489

SCHEMBL7918489

CCCOc1cccc(Nc2nnc(-c3ccccc3)c3ccccc23)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.59
ALDH1A1 P00352 3/20 0.59
HPGD P15428 2/20 0.59
KDM4E B2RXH2 2/20 0.59
PDE5A O76074 1/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
ALOX15 P16050 1/20 0.59
CYP2C19 P33261 1/20 0.59
PDE1A P54750 1/20 0.59
PDE1B Q01064 1/20 0.59
PDE3B Q13370 1/20 0.59
PDE1C Q14123 1/20 0.59
PDE3A Q14432 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
HSD17B10 Q99714 1/20 0.59
TP53 P04637 2/20 0.54
NPSR1 Q6W5P4 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7912132 0.84 CA1 (0.69) MAPTALDH1A1HPGDKDM4EPDE5A
SCHEMBL7913383 0.82 MAPT (0.61) MAPTALDH1A1KDM4ESMN1; SMN2TP53
SCHEMBL7915153 0.82 MAPT (0.61) MAPTALDH1A1HPGDKDM4EPDE5A
SCHEMBL7913343 0.80 MAPT (0.67) MAPTALDH1A1HPGDKDM4EPDE5A
SCHEMBL8022125 0.79 MAPT (0.66) MAPTALDH1A1HPGDKDM4EPDE5A
SCHEMBL8021016 0.79 MAPT (0.62) MAPTALDH1A1HPGDKDM4EPDE5A
SCHEMBL7914861 0.78 MAPT (0.60) MAPTALDH1A1HPGDKDM4EPDE5A
SCHEMBL7905052 0.78 MAPT (0.58) MAPTALDH1A1HPGDKDM4EPDE5A
SCHEMBL7913338 0.77 KDR (0.72) MAPTALDH1A1HPGDKDM4EPDE5A
SCHEMBL7904969 0.77 HTT (0.58) MAPTALDH1A1KDM4ESMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207666-B1 TREATING PRECANCEROUS LESIONS BY ADMINISTERING 4-PHENYLPHTHALAZINE DERIVATIVE CELL PATHWAYS, INC. 2001-03-27 US disclosed